Latest Breaking News On - Innocan pharma corporation - Page 1 : vimarsana.com

Innocan Pharma Reports First Quarter 2024 Results with Revenue Growth of over 4X to $6 8 Million

/PRNewswire/ Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on.

Tel avivInnocan pharmaIris bincovichRoni kamhiBi sky global ltdCompany or innocanInnocan pharma corporationPrnewswire innocan pharma corporationPharma corporationPain managementConsumer wellness

FDA Has Granted Innocan Pharma a Meeting Date for LPT-CBD for Chronic Pain

/PRNewswire/ Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), is pleased to announce significant advancements.

Tel avivUnited statesInnocan pharmaChezy barenholzIris bincovichInnocan pharma corporationUs centers for diseaseBi sky global ltdDrug administrationInvestigational new drugAhuva cernHebrew universityDisease controlConsumer wellness

Innocan Pharma Corporation: FDA Has Granted Innocan Pharma a Meeting Date for LPT-CBD for Chronic Pain

The regulatory approval process with the U.S. Food and Drug Administration has commenced for Innocan's LPT-CBD release technology, marking a key step in the advancement of non-opioid pain management HERZLIYA

United statesTel avivIris bincovichChezy barenholzInnocan pharmaPrnewswire innocan pharma corporationInnocan pharma corporationDrug administrationBi sky global ltdUs centers for diseasePharma corporationInvestigational new drugAhuva cernHebrew universityDisease controlConsumer wellness

Innocan Pharma Corporation: Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey

Innocan Pharma Corporation: Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Tel avivInnocan pharmaIris bincovichChezy barenholzPrnewswire innocan pharma corporationBi sky global ltdInnocan pharma corporationPharma corporationProf chezy barenholzChief scientific officerConsumer wellnessJoint ventureChance des

Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey

Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Tel avivInnocan pharmaIris bincovichChezy barenholzBi sky global ltdInnocan pharma corporationPharma corporationProf chezy barenholzChief scientific officerConsumer wellnessJoint ventureCanada newswire